Pneumococcal vaccines have been instrumental in decreasing invasive disease since their introduction in the 1980s. 2021 brought regulatory changes and recent ACIP recommendations were published in the Morbidity and Mortality Weekly Report, also known as MMWR. Dr. John Schoen, Senior Clinical Manager of Evidence-Based Medicine and Drug Information shares his insights on these changes with host Gretchen Brummel.

Guest speaker:  John Schoen, PharmD, BCPSSenior Clinical Manager of Evidence-Based Medicine and Drug Information Vizient Center for Pharmacy Practice Excellence  Host:  Gretchen Brummel, PharmD, BCPS  Pharmacy Executive Director  Vizient Center for Pharmacy Practice Excellence  

Show Notes:  

Recorded in the Fall of 2023

[01:00-03:34] What’s new since March 2022 with pneumococcal vaccines 

[03:35-06:51] Changes with the adult recommendations

[06:52-13:10] New recommendations from CDC as well as published recommendations for adults

[13:11-19:05] Recommendations for Pneumococcal vaccines in pediatrics

[19:06-21:46] The area of biggest risk moving forward

[21:47-24:07] What we are looking at for the future

Links | Resources:  

Vizient pneumococcal vaccine side-by-side comparison Click Here

ACIP pneumococcal vaccine recommendations Click Here

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Android

RSS Feed